| CXCL8 in tumor biology and its implications for clinical translation X Xiong, X Liao, S Qiu, H Xu, S Zhang, S Wang, J Ai, L Yang Frontiers in molecular biosciences 9, 723846, 2022 | 92 | 2022 |
| Tumor antigens and immune subtypes guided mRNA vaccine development for kidney renal clear cell carcinoma H Xu, X Zheng, S Zhang, X Yi, T Zhang, Q Wei, H Li, J Ai Molecular cancer 20, 1-7, 2021 | 54 | 2021 |
| Antitumor activity and treatment-related toxicity associated with nivolumab plus ipilimumab in advanced malignancies: a systematic review and meta-analysis H Xu, P Tan, J Ai, S Zhang, X Zheng, X Liao, L Yang, Q Wei Frontiers in pharmacology 10, 1300, 2019 | 19 | 2019 |
| Cryotherapy shows no inferiority compared with radical Prostatectomy for low-risk and intermediate-risk localized Prostate Cancer: a real-world study from the SEER database K Jin, S Qiu, X Zheng, Y Li, S Zhang, J Li, X Liao, X Tu, L Yang, Q Wei Journal of Cancer 11 (19), 5738, 2020 | 13 | 2020 |
| Associations between the dietary inflammatory index and urinary incontinence among women younger than 65 years S Zhang, H Bian, S Qiu, B Cai, K Jin, X Zheng, J Li, X Tu, J Ai, L Yang, ... Scientific Reports 11 (1), 9340, 2021 | 12 | 2021 |
| Detection of prostatic inflammation from peripheral lymphocyte count and free/total PSA ratio in men with LUTS/BPH X Liao, Z Tang, J Ai, H Xu, S Zhang, L Liu, S Qiu, P Tan, Y Fan, L Yang, ... Frontiers in Pharmacology 11, 589, 2020 | 12 | 2020 |
| Partial nephrectomy vs cryoablation for T1a renal cell carcinoma: A comparison of survival benefit stratified by tumour size X Liao, S Qiu, W Wang, X Zheng, K Jin, S Zhang, Y Bao, L Yang, Q Wei Cancer Epidemiology 59, 221-226, 2019 | 12 | 2019 |
| The prognostic value of the systemic immune-inflammation index for patients with bladder cancer after radical cystectomy S Zhang, J Du, X Zhong, P Tan, H Xu, J Zhang, D Jin, Y Li, W Le, X Xiong, ... Frontiers in Immunology 13, 1072433, 2022 | 10 | 2022 |
| Utilizing the lactate dehydrogenase-to-albumin ratio for survival prediction in patients with bladder cancer after radical cystectomy H Xu, T Lin, J Ai, J Zhang, S Zhang, Y Li, X Zheng, P Zhang, Q Wei, P Tan, ... Journal of Inflammation Research, 1733-1744, 2023 | 5 | 2023 |
| Targeting histone modifiers in bladder cancer therapy—preclinical and clinical evidence S Zhang, T Lin, X Xiong, C Chen, P Tan, Q Wei Nature Reviews Urology 21 (8), 495-511, 2024 | 4 | 2024 |
| Different predictive values of microvessel density for biochemical recurrence among different PCa populations: A systematic review and meta‐analysis J Jiang, J Li, X Xiong, S Zhang, D Tan, L Yang, Q Wei Cancer Medicine 12 (3), 2166-2178, 2023 | 4 | 2023 |
| Second-line treatment options in metastatic castration-resistant prostate cancer after progression on first-line androgen-receptor targeting therapies: A systematic review and … X Xiong, S Zhang, W Zheng, X Liao, J Yang, H Xu, S Hu, Q Wei, L Yang Critical Reviews in Oncology/Hematology 196, 104286, 2024 | 3 | 2024 |
| Clinical benefit and safety associated with mRNA vaccines for advanced solid tumors: A meta‐analysis T Zhang, H Xu, X Zheng, X Xiong, S Zhang, X Yi, J Li, Q Wei, J Ai MedComm 4 (4), e286, 2023 | 3 | 2023 |
| Which type of exercise during radiation therapy is optimal to improve fatigue and quality of life in men with prostate cancer? A Bayesian network analysis X Xiong, B Zeng, S Zhang, J Du, X Liao, S Hu, X Su, S Qiu, L Yang European Urology Open Science 43, 74-86, 2022 | 3 | 2022 |
| The efficacy and safety of stereotactic body radiotherapy combined with systematic therapy for metastatic renal cell carcinoma: a systematic review and meta‐analysis S Zhang, X Xiong, N Xie, W Zheng, Y Li, T Lin, Q Wei, P Tan MedComm 5 (5), e544, 2024 | 2 | 2024 |
| An umbrella review of the evidence associating occupational carcinogens and cancer risk at 19 anatomical sites X Xiong, S Zhang, X Liao, J Du, W Zheng, S Hu, Q Wei, L Yang Environmental Pollution 345, 123531, 2024 | 2 | 2024 |
| Survival impact of concomitant squamous differentiation in upper tract urothelial carcinoma patients receiving adjuvant chemotherapy. J Ye, X Liao, S Zhang, Q Wei, Y Bao Journal of Clinical Oncology 43 (5_suppl), 729-729, 2025 | | 2025 |
| A platform of functional studies of ESCC-associated gene mutations identifies the roles of TGFBR2 in ESCC progression and metastasis J Wang, J Du, X Luo, L Guo, Y Liu, J Zhou, Y Zou, Z Lu, X Pan, X Chen, ... Cell Reports 43 (11), 2024 | | 2024 |
| Androgen-ablative therapies inducing CXCL8 regulates mTORC1/SREBP2-dependent cholesterol biosynthesis to support progression of androgen receptor negative prostate cancer cells X Xiong, S Zhang, W Zhu, J Du, X Liao, S Hu, J Yang, W Zheng, S Qiu, ... Oncogene 43 (47), 3456-3468, 2024 | | 2024 |